Long-Acting HIV Drugs Show Early Promise in People Who Struggle to Control the Virus with Daily Pills

All 46 people at one clinic in San Francisco, in the United States, who were given a mix of long-lasting HIV injections reached and kept control of the virus, a new report has found.

Many of them had found daily pills hard to take.

The study was small and had no comparison group, so it shows early promise, not proof.

The short research letter was published on 8 October 2026 in JAMA Network Open, a medical journal.

It was written by researchers at the University of California San Francisco, led by Nathanael Gistand and Monica Gandhi.

Why this matters

Long-lasting treatment means injections that keep working for a long time, so patients do not need a pill every day.

Only one such combination is approved: cabotegravir with rilpivirine, first approved in 2021 for people whose virus was already under control.